arrow
Back
J

Julián Panés

University of Barcelona

108H-index
1.0KPaper Count
4.9WCitation Count
Published Papers 385
Publication Date
Recommendations to Standardize the Conduct of Clinical Trials Evaluating Novel Therapies for Perianal Fistulizing Crohn’s Disease
err2025-11-19
err0
PREAI
errSudheer Kumar Vuyyuru; Jurij Hanzel; Mantaj S. Brar; Silvio Danese; Geert D'Haens; William A. Faubion; Brian G. Feagan; Ailsa Hart; Paulo G. Kotze; Matthew J. Lee; Remo Panaccione; Julian Panes; Laurent Peyrin-Biroulet; Jordi Rimola; Bruce E. Sands; Cynthia S. Santillan; Johnathan P. Segal; Jaap Stoker; Stuart A. Taylor; Susan Archer
errShare
errSave
An international consensus on the design of clinical trials for advanced combination treatment (ACT) in inflammatory bowel disease
err2025-10-23
err0
errOAAI
errVirginia Solitano; Jurij Hanžel; Christopher Ma; Robert Battat; Tim Raine; Britta Siegmund; Laurent Peyrin-Biroulet; Bram Verstockt; Joana Torres; Saurabh Mehandru; Geert D'Haens; Malcolm Hogan; Federica Ungaro; Raja Atreya; Julian Panés; Remo Panaccione; Claire E. Parker; Bruce E. Sands; Brian G. Feagan; Silvio Danese; Vipul Jairath
errShare
errSave
Upadacitinib Maintenance Therapy in Crohn’s Disease: Final Results From the Randomized Phase 3 U-ENDURE Study
err2025-07-28
err0
PREAI
errRemo Panaccione; Miguel Regueiro; Scott D. Lee; Raja Atreya; Gitte Pedersen; Efrat Broide; Cristina Rodriguez; Adriaan A. van Bodegraven; Elena Dubcenco; Ana P. Lacerda; Tian Feng; Ziqian Geng; Tao Wang; Stijn van Haaren; Samuel I. Anyanwu; Julian Panés
errShare
errSave
Volumetric Changes in Perianal Fistulizing Crohn's Disease Measured by Magnetic Resonance Is Feasible and Could Be a Potential Biomarker to Predict Clinical Outcomes
err2025-07-18
err0
errOAAI
errBerta Caballol; Ingrid Ordás; Carolina Saavedra; Julia Saidman; Maria Carmen Masamunt; Marta Gallego; Rebeca Barastegui; Agnès Fernández-Clotet; Alex Menys; Julian Panés; Elena Ricart; Jordi Rimola
errShare
errSave
Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials
err2025-07-17
err0
PREAI
errRemo Panaccione; Brian G Feagan; Anita Afzali; David T Rubin; Walter Reinisch; Julián Panés; Silvio Danese; Tadakazu Hisamatsu; Natalie A Terry; Leonardo Salese; Rian Van Rampelbergh; Aparna Sahoo; Marion L Vetter; Jacqueline Yee; Chenglong Han; Mary Ellen Frustaci; Kitty Y Y Wan; Zijiang Yang; Jewel Johanns; Jane M Andrews; Geert R D'Haens; Bruce E Sands
errShare
errSave
1118a: A PHASE 2A, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO ASSESS THE SAFETY, PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF AGMB-129 IN PATIENTS WITH FIBROSTENOTIC CROHN’S DISEASE: INTERIM RESULTS FROM THE STENOVA TRIAL
err2025-07-03
err0
PREAI
errFlorian Rieder; Julián Panés; Brian G. Feagan; Sonja Heeren; Jaroslaw Kierkus; Cathy Lu; Anja Poulsen; Pieter-Jan Stiers; Kim Thys; Reginald Brys; Margreke Brill; Carmen Fleurinck; Rolf van Heeswijk; Andrea Saez Borderias; Tim Van Kaem; Philippe Wiesel
errShare
errSave
Achievement of long-term treatment goals in upadacitinib-treated patients with moderately to severely active ulcerative colitis: a post hoc analysis of phase 3 trial data
err2025-07-01
err2
PREAI
errPanes, Julian; Dubinsky, Marla C.; Ishiguro, Yoh; Shukla, Nidhi; Dubcenco, Elena; Remple, Valencia; Sharma, Dolly; Panaccione, Remo
errShare
errSave
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease
err2025-05-28
err0
errOAAI
errJurij Hanžel; Virginia Solitano; Sudheer Kumar Vuyyuru; Remo Panaccione; Bruce E. Sands; Laurent Peyrin-Biroulet; Silvio Danese; Geert R. D'Haens; Raja Atreya; Matthieu Allez; Charles N. Bernstein; Peter Bossuyt; Brian Bressler; Robert V. Bryant; Benjamin L. Cohen; Jean-Frederic Colombel; Ferdinando D’Amico; Axel Dignass; Marla Dubinsky; Phillip Fleshner; Richard B. Gearry; Stephen B. Hanauer; Ailsa L. Hart; Maia Kayal; Torsten Kucharzik; Peter L. Lakatos; Edouard Louis; Fernando Magro; Neeraj Narula; Rupert W. Leong; Julián Panés; Tim Raine; Zhihua Ran; Miguel D. Regueiro; Walter Reinisch; Siddharth Singh; A. Hillary Steinhart; Simon Travis; Ryan C. Ungaro; C. Janneke van der Woude; Takayuki Yamamoto; Vineet Ahuja; David T. Rubin; Parambir S. Dulai; Linda J. Cornfield; Malcolm Hogan; William J. Sandborn; Brian G. Feagan; Vipul Jairath; Christopher Ma
errShare
errSave
Definitions, diagnosis, and management of postoperative recurrence in Crohn's disease patients with permanent ileostomy-a systematic review and meta-analysis
err2025-04-01
err0
PREAI
errAbushamma, Suha; Yadete, Tesfaye; Nero, Neil; Falloon, Katherine; Parker, Claire E.; Abreu, Maria T.; Ahuja, Vineet; Armuzzi, Alessandro; Bemelman, Willem; Bruining, David H.; Deepak, Parakkal; Dignass, Axel; Dotan, Iris; Feagan, Brian G.; Fulmer, Clifton; Halfvarson, Jonas; Hart, Ailsa; Holubar, Stefan D.; Leong, Rupert W.; Ma, Christopher; Magro, Fernando; McCurdy, Jeffrey D.; Narula, Neeraj; Panes, Julian; Raine, Tim; Regueiro, Miguel; Rogler, Gerhard; Singh, Siddharth; Sparrow, Miles P.; Spinelli, Antonino; Van Koughnett, Julie Ann; Vuyyuru, Sudheer K.; Solitano, Virginia; Yuan, Yuhong; Jairath, Vipul; Rieder, Florian
errShare
errSave
Potential predictors of efficacy outcomes following tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a post hoc analysis of outcomes from the RIVETING study
err2025-02-27
err0
errOAAI
errJoana Torres; Geert R. D’Haens; Miguel Regueiro; Genoile Santana; Julian Panés; Séverine Vermeire; Sean Gardiner; Nicole Kulisek; Irene Modesto; Chinyu Su; Nervin Lawendy; Rajiv Mundayat; Jerome Paulissen; Marla C. Dubinsky
errShare
errSave
Mitochondrial Dysfunction: Unraveling the Elusive Biology Behind Anti-TNF Response During Ulcerative Colitis
err2025-02-13
err0
PREAI
errKioroglou, Dimitrios; Pena-Cearra, Ainize; Corraliza, Ana M.; Seoane, Iratxe; Castelo, Janire; Panes, Julian; Gomez-Irwin, Laura; Rodriguez-Lago, Iago; de Zarate, Jone Ortiz; Fuertes, Miguel; Martin-Ruiz, Itziar; Gonzalez, Monika; Aransay, Ana M.; Salas, Azucena; Rodriguez, Hector; Anguita, Juan; Abecia, Leticia
errShare
errSave
Extended Risankizumab Treatment in Patients With Crohn’s Disease Who Did Not Achieve Clinical Response to Induction Treatment
err2025-02-03
err0
errOAAI
errRemo Panaccione; Marc Ferrante; Iris Dotan; Julian Panés; Tadakazu Hisamatsu; Peter Bossuyt; Silvio Danese; Alexandra Song; Jasmina Kalabic; Namita Joshi; Javier Zambrano; Yafei Zhang; W. Rachel Duan; Kristina Kligys; Marla C. Dubinsky; James O. Lindsay; Severine Vermeire; Britta Siegmund; Peter M. Irving; Geert D’Haens
errShare
errSave
Building a Robust Artificial Intelligence Solution for Use in Ulcerative Colitis Clinical Trials
err2025-01-22
err0
PREAI
errByrne, M.; Requa, J.; Panes, J.; Bressler, B.; Panaccione, R.; Mendel, R.; East, J. E.; Parsa, N.; Banerjee, R.; Kalapala, R.; Reddy, D. N.; Rughwani, H. R.; Flegg, D.; Moran, G.; Gallinger, Z.; Cheung, V; Tan, M.; Ma, C.; Travis, S. P.; Jairath, V
errShare
errSave
Achieving early symptom resolution and endoscopic outcomes is associated with improved long-term outcomes in ulcerative colitis: A post-hoc analysis of INSPIRE and COMMAND studies
err2025-01-22
err0
PREAI
errTorres, J. Tinoco da Silva; Danese, S.; Tanida, S.; Dulai, P. S.; Xuan, S.; Kalabic, J.; Morisset, P.; Vladea, R.; Sharma, D.; Panes, J.
errShare
errSave
TL1A-activated T cells as upstream regulators of perianal fistulizing disease-associated changes in the rectum of Crohn's Disease patients
err2025-01-22
err0
PREAI
errGudino, V; Cho, J. W.; Caballol, B.; Corraliza, A. M.; Veny, M.; Sanzo-Machuca, A.; Genaro, L.; Melon-Ardanaz, E.; Masamunt, M. C.; Esteller, M.; Fernandez-Clotet, A.; Ordas, I; Franco-Leal, R.; Ricart, E.; Panes, J.; Hemberg, M.; Salas, A.
errShare
errSave
Safety of guselkumab in Inflammatory Bowel Disease up to 1 year: Integrated safety analysis of phase 2 and 3 studies in Crohn's Disease and Ulcerative Colitis
err2025-01-22
err0
PREAI
errSands, B. E.; Panaccione, R.; Danese, S.; Panes, J.; Hisamatsu, T.; D'Haens, G.; Van Rampelbergh, R.; Olurinde, M.; Yee, J.; Baker, T.; Yarandi, S.; Germinaro, M.; Vetter, M. L.; Li, H.; Ballina, M. Rosas; Allegretti, J.; Afzali, A.; Rubin, D. T.
errShare
errSave
Corticosteroid sparing effects of treatment with guselkumab in patients with moderate to severely active Crohn's disease: Phase 3 GALAXI 2/3 results through week 48
err2025-01-22
err1
PREAI
errPanes, J.; Hisamatsu, T.; Armuzzi, A.; Terry, N. A.; Salese, L.; Van Rampelbergh, R.; Yee, J.; Wan, K. Y.; Yang, Z.; Pin, S.; Sands, B. E.; Rubin, D. T.
errShare
errSave
Predictive modeling to evaluate long-term treatment effectiveness of darvadstrocel in patients with complex perianal fistulas in Crohn's disease
err2024-12-30
err0
errOAAI
errKarki, Chitra; Hantsbarger, Gary; Turkstra, Erika; Fenu, Elisabetta; Genenz, Ken; Gilaberte, Inmaculada; Panes, Julian
errShare
errSave
A Randomized Phase II Study of Efmarodocokin Alfa, an interleukin-22 Agonist, Versus Vedolizumab in Patients With Ulcerative Colitis
err2024-12-16
err0
errOAAI
errSilvio Danese; Michael E. Rothenberg; Jeremy J. Lim; Han Ting Ding; Jacqueline M. McBride; Yiling Chen; Ajit Dash; Jordan S. Mar; Mary Keir; Laurent Peyrin-Biroulet; Julian Panes; Jean-Frederic Colombel; Brian Feagan; John F. Valentine; Stefan Schreiber
errShare
errSave